Coronavirus disease 2019 (COVID-19) was detected in China during the 2019–2020 seasonal influenza epidemic. Non-pharmaceutical interventions (NPIs) and behavioral changes to mitigate COVID-19 could have affected transmission dynamics of influenza and other respiratory diseases. By comparing 2019–2020 seasonal influenza activity through March 29, 2020 with the 2011–2019 seasons, we found that COVID-19 outbreaks and related NPIs may have reduced influenza in Southern and Northern China and the United States by 79.2% (lower and upper bounds: 48.8%–87.2%), 79.4% (44.9%–87.4%) and 67.2% (11.5%–80.5%). Decreases in influenza virus infection were also associated with the timing of NPIs. Without COVID-19 NPIs, influenza activity in China and the United States would likely have remained high during the 2019–2020 season. Our findings provide evidence that NPIs can partially mitigate seasonal and, potentially, pandemic influenza. Non-pharmaceutical interventions (NPIs) implemented to interrupt COVID-19 transmission may also impact the spread of other infectious diseases. Here, the authors estimate that influenza activity in China and the United States reduced by up to 80% when NPIs were in place in the 2019–2020 season.
【저자키워드】 SARS-CoV-2, Epidemiology, viral epidemiology, Preventive medicine, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, pandemic, Infectious diseases, Diseases, Influenza, Infection, Intervention, Influenza virus, respiratory diseases, Spread, China, Epidemic, COVID-19 outbreak, Transmission dynamics, NPIs, United States, virus infection, respiratory, Evidence, NPI, COVID-19 transmission, other infectious diseases, Seasonal influenza, decreases, mitigate, decrease, affected, the United State, remained, reduced, the timing, 【제목키워드】 Influenza, Intervention, China, COVID-19 outbreak, Impact, the United State,